Michael Weiss is the founder of TG Therapeutics. He has held his current roles at TG Therapeutics since December 2011.
Michael S. Weiss is the Chairman, President, and Chief Executive Officer of TG Therapeutics, a company that recently reported strong financial results for the fourth quarter and full year 2025, driven by the continued momentum of BRIUMVI. He has held his current roles at TG Therapeutics since December 2011. Prior to this, he was Chairman and CEO of Keryx Biopharmaceuticals, Inc. from 2002 to 2009. He also co-founded and served as Co-Portfolio Manager and Managing Partner of Opus Point Partners, LLC from 2009 to 2019.
Full founder directory · Investor directory · Company funding database · Fundraising library